GLP-1 Receptor Agonists
GLP-1 Receptor Agonists is a pharmaceutical drug with 5 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
4
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
Clinical Trials (5)
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5